Risk of malignancy in patients with rheumatoid arthritis after anti-tumor necrosis factor therapy: results from Korean National Health Insurance claims data

BACKGROUND/AIMS: Inhibition of tumor necrosis factor (TNF) is an effective treatment for rheumatoid arthritis (RA), but safety concerns about malignancy remain. The aim of this study was to evaluate cancer risk in RA patients treated with TNF inhibitors (TNFi), based on Korean Nationwide Health Insu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Korean J Intern Med
Main Authors: Jung, Seung Min, Kwok, Seung-Ki, Ju, Ji Hyeon, Park, Yong-Beom, Park, Sung-Hwan
Formato: Artigo
Idioma:Inglês
Publicado em: The Korean Association of Internal Medicine 2019
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6506746/
https://ncbi.nlm.nih.gov/pubmed/29172405
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3904/kjim.2016.374
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados